The global market for women’s health therapeutics is expected to grow to $22.5 billion by 2018, with a five-year compound annual growth rate (CAGR) of 3.5%. The postmenopausal osteoporosis therapeutics segment leads the global market, claiming 53% market share.

1. Global Market for Women’s Health Therapeutics Expected to Reach $22.5 Billion in 2018;
Postmenopausal Osteoporosis Claims 53% Market Share
Wellesley, Mass., May 27, 2014 – BCC Research (www.bccresearch.com) reveals in its new report,
Therapeutics for Women's Health: Technologies and Global Markets, the global market for women’s
health therapeutics is expected to grow to $22.5 billion by 2018, with a five-year compound annual
growth rate (CAGR) of 3.5%. The postmenopausal osteoporosis therapeutics segment leads the global
market, claiming 53% market share.
Women’s health issues have gained significant market attention recently as a result of disease pattern and
treatment differences between men and women. The U.S. segment, by far the largest- and fastest-growing
regional market, is expected to reach $13.5 billion by 2018, registering a CAGR of 4.7%.
The European and Japanese markets are projected to approach $7.5 billion and nearly $1.4 billion,
respectively, by 2018, at CAGRs of 1.7% and 1.8%.
Currently, postmenopausal osteoporosis dominates the global market for women’s health therapeutics and
technologies, followed by menopause, endometriosis, and polycystic ovary syndrome, which claim 30%,
14%, and 4% of the total market, respectively.
“Patent expiry is one of the key challenges for the growth of this market and has resulted in a slowdown
in recent few years due to patent expiries of blockbusters such as Evista, the Premarin family, Actonel,
and other drugs,” says BCC Research biotechnology analyst Dr. Ritu Thakur Dangi. “However, the
launch of novel therapies (e.g., elagolix, odanacatib, Femitra, among others) in the late-stage pipeline has
the strong potential to drive the market during the forecast period.”
THERAPEUTICS FOR WOMEN'S HEALTH: TECHNOLOGIES AND GLOBAL MARKETS
provides an overview of the global market for women’s health therapeutics. It includes analyses of global
market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
Editors and reporters who wish to speak with the analyst, should contact Steven Cumming at
steven.cumming@bccresearch.com.
About BCC Research
BCC Research publishes market research reports that make organizations worldwide more profitable with
intelligence that drives smart business decisions. These reports cover today's major industrial and
technology sectors, including emerging markets. For more than 40 years we've helped customers identify
new market opportunities with accurate and reliable data and insight, including market sizing, forecasting,
industry overviews, and identification of significant trends and key competitors. We partner with analysts
who are experts in specific areas of industry and technology, providing unbiased measurements and
assessments of global markets. Our clients include the top companies in industries around the world as
well as universities, business schools, start-ups, consulting firms and investment companies. BCC
Research is a unit of Eli Research LLC. Visit our website at www.bccresearch.com. Contact us: (+1) 781-
489-7301 (U.S. Eastern time), or email information@bccresearch.com.
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC
Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email:
editor@bccresearch.com as the source and publisher. Thank you.